These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16767106)

  • 1. Angiotensin II-dependent Src and Smad1 signaling pathway is crucial for the development of diabetic nephropathy.
    Mima A; Matsubara T; Arai H; Abe H; Nagai K; Kanamori H; Sumi E; Takahashi T; Iehara N; Fukatsu A; Kita T; Doi T
    Lab Invest; 2006 Sep; 86(9):927-39. PubMed ID: 16767106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Smad1 is directly associated with mesangial matrix expansion in rat diabetic nephropathy.
    Matsubara T; Abe H; Arai H; Nagai K; Mima A; Kanamori H; Sumi E; Takahashi T; Matsuura M; Iehara N; Fukatsu A; Kita T; Doi T
    Lab Invest; 2006 Apr; 86(4):357-68. PubMed ID: 16482100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the BMP4/Smad1 signaling pathway in mesangial cell proliferation: A possible mechanism of diabetic nephropathy.
    Chen C; Lin J; Li L; Zhu T; Gao L; Wu W; Liu Q; Ou S
    Life Sci; 2019 Mar; 220():106-116. PubMed ID: 30708099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Src kinase blocks high glucose-induced EGFR transactivation and collagen synthesis in mesangial cells and prevents diabetic nephropathy in mice.
    Taniguchi K; Xia L; Goldberg HJ; Lee KW; Shah A; Stavar L; Masson EA; Momen A; Shikatani EA; John R; Husain M; Fantus IG
    Diabetes; 2013 Nov; 62(11):3874-86. PubMed ID: 23942551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary Smad1 is a novel marker to predict later onset of mesangial matrix expansion in diabetic nephropathy.
    Mima A; Arai H; Matsubara T; Abe H; Nagai K; Tamura Y; Torikoshi K; Araki M; Kanamori H; Takahashi T; Tominaga T; Matsuura M; Iehara N; Fukatsu A; Kita T; Doi T
    Diabetes; 2008 Jun; 57(6):1712-22. PubMed ID: 18285555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Src mediates PDGF-induced Smad1 phosphorylation and contributes to the progression of glomerulosclerosis in glomerulonephritis.
    Mima A; Abe H; Nagai K; Arai H; Matsubara T; Araki M; Torikoshi K; Tominaga T; Iehara N; Fukatsu A; Kita T; Doi T
    PLoS One; 2011 Mar; 6(3):e17929. PubMed ID: 21445358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription factor 7-like 2 (TCF7L2) regulates activin receptor-like kinase 1 (ALK1)/Smad1 pathway for development of diabetic nephropathy.
    Araoka T; Abe H; Tominaga T; Mima A; Matsubara T; Murakami T; Kishi S; Nagai K; Doi T
    Mol Cells; 2010 Sep; 30(3):209-18. PubMed ID: 20803090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel phosphoinositide 3-kinase-dependent pathway for angiotensin II/AT-1 receptor-mediated induction of collagen synthesis in MES-13 mesangial cells.
    Yano N; Suzuki D; Endoh M; Zhao TC; Padbury JF; Tseng YT
    J Biol Chem; 2007 Jun; 282(26):18819-30. PubMed ID: 17493931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative regulation of Smad1 pathway and collagen IV expression by store-operated Ca
    Wu P; Ren Y; Ma Y; Wang Y; Jiang H; Chaudhari S; Davis ME; Zuckerman JE; Ma R
    Am J Physiol Renal Physiol; 2017 Jun; 312(6):F1090-F1100. PubMed ID: 28298362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Camel milk attenuates the biochemical and morphological features of diabetic nephropathy: inhibition of Smad1 and collagen type IV synthesis.
    Korish AA; Abdel Gader AG; Korashy HM; Al-Drees AM; Alhaider AA; Arafah MM
    Chem Biol Interact; 2015 Mar; 229():100-8. PubMed ID: 25617480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. All-trans retinoic acid suppresses bone morphogenetic protein 4 in mouse diabetic nephropathy through a unique retinoic acid response element.
    Tamaki M; Tominaga T; Fujita Y; Koezuka Y; Ichien G; Murakami T; Kishi S; Yamamoto K; Abe H; Nagai K; Doi T
    Am J Physiol Endocrinol Metab; 2019 Mar; 316(3):E418-E431. PubMed ID: 30601699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The current clinical problems for early phase of diabetic nephropathy and approach for pathogenesis of diabetic nephropathy.
    Doi T; Mima A; Matsubara T; Tominaga T; Arai H; Abe H
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S21-4. PubMed ID: 18842318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II blockade prevents hyperglycemia-induced activation of JAK and STAT proteins in diabetic rat kidney glomeruli.
    Banes AK; Shaw S; Jenkins J; Redd H; Amiri F; Pollock DM; Marrero MB
    Am J Physiol Renal Physiol; 2004 Apr; 286(4):F653-9. PubMed ID: 14678947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type IV collagen is transcriptionally regulated by Smad1 under advanced glycation end product (AGE) stimulation.
    Abe H; Matsubara T; Iehara N; Nagai K; Takahashi T; Arai H; Kita T; Doi T
    J Biol Chem; 2004 Apr; 279(14):14201-6. PubMed ID: 14732718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone Morphogenetic Protein 4 and Smad1 Mediate Extracellular Matrix Production in the Development of Diabetic Nephropathy.
    Matsubara T; Araki M; Abe H; Ueda O; Jishage K; Mima A; Goto C; Tominaga T; Kinosaki M; Kishi S; Nagai K; Iehara N; Fukushima N; Kita T; Arai H; Doi T
    Diabetes; 2015 Aug; 64(8):2978-90. PubMed ID: 25995358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nox4 NAD(P)H oxidase mediates Src-dependent tyrosine phosphorylation of PDK-1 in response to angiotensin II: role in mesangial cell hypertrophy and fibronectin expression.
    Block K; Eid A; Griendling KK; Lee DY; Wittrant Y; Gorin Y
    J Biol Chem; 2008 Aug; 283(35):24061-76. PubMed ID: 18559349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin(1-7) attenuates the progression of streptozotocin-induced diabetic renal injury better than angiotensin receptor blockade.
    Zhang K; Meng X; Li D; Yang J; Kong J; Hao P; Guo T; Zhang M; Zhang Y; Zhang C
    Kidney Int; 2015 Feb; 87(2):359-69. PubMed ID: 25075768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gas6 induces Akt/mTOR-mediated mesangial hypertrophy in diabetic nephropathy.
    Nagai K; Matsubara T; Mima A; Sumi E; Kanamori H; Iehara N; Fukatsu A; Yanagita M; Nakano T; Ishimoto Y; Kita T; Doi T; Arai H
    Kidney Int; 2005 Aug; 68(2):552-61. PubMed ID: 16014032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucose.
    Amiri F; Shaw S; Wang X; Tang J; Waller JL; Eaton DC; Marrero MB
    Kidney Int; 2002 May; 61(5):1605-16. PubMed ID: 11967010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of bone morphogenetic protein 4 signaling leads to glomerulosclerosis that mimics diabetic nephropathy.
    Tominaga T; Abe H; Ueda O; Goto C; Nakahara K; Murakami T; Matsubara T; Mima A; Nagai K; Araoka T; Kishi S; Fukushima N; Jishage K; Doi T
    J Biol Chem; 2011 Jun; 286(22):20109-16. PubMed ID: 21471216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.